![D.A. Wallach – Investing in Healthcare - [Invest Like the Best, EP.166]](https://megaphone.imgix.net/podcasts/0b605690-ccce-11ed-87bf-9b8d1c646e08/image/DA_Wallach.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress)
Invest Like the Best with Patrick O'Shaughnessy
D.A. Wallach – Investing in Healthcare - [Invest Like the Best, EP.166]
Conversations with the best investors and business leaders in the world. We explore their ideas, methods, and stories to help you better invest your time and money. Hear stock market and boardroom insights you can't find anywhere else. If you're a professional investor, CEO, entrepreneur, or business strategist, this is for you. Explore all our episodes and learn more at https://www.colossus.com
Show Notes
Tap timecodes to jump
My guest today is D.A. Wallach, one of the more interesting investors I’ve come across. He is the former lead singer of the group Chester French and the former artist-in-residence at Spotify, where he was also an early investor. While he’s also an early investor in companies like SpaceX, his focus the last 5 years has been on early stage health care investing, which is the topic of this conversation. We discuss the entire life sciences and heath care investing ecosystem. This was recorded in the very early days of the Coronavirus outbreak so while we touch on it briefly it isn’t the primary focus, and I intend on returning to more traditional episodes like this one in the coming weeks, meant to be evergreen conversations. Please enjoy my conversation with D.A. Wallach.
For more episodes go to InvestorFieldGuide.com/podcast.
Sign up for the book club, where you’ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub.
Follow Patrick on Twitter at @patrick_oshag
Show Notes
– (First question) – Where is interest in healthcare started
– How to categorize health services
– The product of medicine
– How medicine is changing in 2020
– What is enabling innovation in medicine
– Manufacturing of solutions, gene therapy example
– Using CRISPR
– Pros and cons, and the morality of gene intervention
– How progress is being made in medical breakthroughs
– What is the business and investment world seeing on the longevity side
– What is next in the wearable medical tracking trend
– The personalization of medical treatments
– How he thinks about all of this from an investing standpoint
– Exiting these companies
– How he thinks about founders in this space
– Drug prices
– The Paradox of Pricing
– What will lead to a change in the pricing of drugs
– The delivery side of healthcare
– Investments that could improve the delivery side of healthcare
– Thoughts on the anti-interventionist line of thinking in the medical world
– Lessons from his health portfolio
– Other frontiers that pique his interest, including gut biome
– His career in music
– Lessons he learned during his time in the music industry
– Opportunities in the music industry as an investor
– Kindest thing anyone has done for DA
Learn More
For more episodes go to InvestorFieldGuide.com/podcast.
Sign up for the book club, where you’ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub
Follow Patrick on Twitter at @patrick_oshag
This episode is not processed yet. Sign in to queue the transcript and make it useful for search and Q&A.
Sign in to queue transcript (1 credit)
Free to start
Skim the episode first,
Skim the episode first,
then decide if it is worth listening.
Sign up with Google in one click. 10 transcript credits included. No card needed.
Google sign-in · No credit card · 10 free transcript credits